32 results on '"Hindorf, Ulf"'
Search Results
2. Genotyping should be considered the primary choice for pre-treatment evaluation of thiopurine methyltransferase function
3. Short and long-term efficacy of adalimumab in ulcerative colitis: a real-life study
4. Muscular exercise can cause highly pathological liver function tests in healthy men
5. Thiopurines in Inflammatory Bowel Disease - The Role of Pharmacogenetics and Therapeutic Drug Monitoring
6. Humoral response toClostridium difficilein inflammatory bowel disease, including correlation with immunomodulatory treatment
7. Humoral response to Clostridium difficile in inflammatory bowel disease, including correlation with immunomodulatory treatment.
8. A skewed thiopurine metabolism is a common clinical phenomenon that can be successfully managed with a combination of low-dose azathioprine and allopurinol
9. Changes of activity and isoforms of alkaline sphingomyelinase (nucleotide pyrophosphatase phosphodiesterase 7) in bile from patients undergoing endoscopic retrograde cholangiopancreatography.
10. A preliminary study of modeling and simulation in individualized drug dosage – azathioprine on inflammatory bowel disease
11. Changes of activity and isoforms of alkaline sphingomyelinase (nucleotide pyrophosphatase phosphodiesterase 7) in bile from patients undergoing endoscopic retrograde cholangiopancreatography
12. A skewed thiopurine metabolism is a common clinical phenomenon that can be successfully managed with a combination of low-dose azathioprine and allopurinol
13. Letter: TPMT status determination: The simplest is the most effective? Reply : Reply to Dr. Chouchana's letter
14. The Role of Inosine-5'-Monophosphate Dehydrogenase in Thiopurine Metabolism in Patients With Inflammatory Bowel Disease
15. Characterisation and utility of thiopurine methyltransferase and thiopurine metabolite measurements in autoimmune hepatitis.
16. Modern läkemedelsterapi vid Crohn [Current drug therapy in Crohn disease] : nationella riktlinjer [national guidelines]
17. Pharmacogenetics during standardised initiation of thiopurine treatment in inflammatory bowel disease
18. Adverse events leading to modification of therapy in a large cohort of patients with inflammatory bowel disease
19. Thiopurines in inflammatory bowel disease - The role of pharmacogenetics and therapeutic drug monitoring
20. High methylthioinosine monophosphate levels as a cause of myelotoxicity when introducing thiopurine therapy in patients with inflammatory bowel disease
21. No induction of thiopurine methyltransferase (TPMT) during thiopurine treatment in IBD
22. Reply to Dr. Chouchana's letter
23. How are thiopurines used and monitored by Swedish gastroenterologists when treating patients with inflammatory bowel disease?
24. The Role of Inosine-5′-Monophosphate Dehydrogenase in Thiopurine Metabolism in Patients With Inflammatory Bowel Disease
25. Characterisation and utility of thiopurine methyltransferase and thiopurine metabolite measurements in autoimmune hepatitis
26. W1208 A ‘Skewed’ Thiopurine Metabolite Profile in IBD Patients Is Not Explained By Variations in Inosine-5-Monophosphate Dehydrogenase Activity
27. Assessment of Thiopurine Methyltransferase and Metabolite Formation During Thiopurine Therapy
28. Drug monitoring of azathioprine (AZA) and 6-mercaptopurine (6-MP) among adult patients with inflammatory bowel disease (IBD)
29. Changes of activity and isoforms of alkaline sphingomyelinase (nucleotide pyrophosphatase phosphodiesterase 7) in bile from patients undergoing endoscopic retrograde cholangiopancreatography.
30. Therapeutic drug monitoring of thiopurines in inflammatory bowel disease : Evaluating the benefit of measuring mono-, di-, and triphosphates separately
31. Humoral response to Clostridium difficile in inflammatory bowel disease, including correlation with immunomodulatory treatment.
32. [Current drug therapy in Crohn disease--national guidelines].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.